Comparison of neurogenic effects of fluoxetine, duloxetine and running in mice - PubMed (original) (raw)

Comparative Study

Comparison of neurogenic effects of fluoxetine, duloxetine and running in mice

Michael W Marlatt et al. Brain Res. 2010.

Abstract

Hippocampal neurogenesis can be regulated by extrinsic factors, such as exercise and antidepressants. While there is evidence that the selective serotonin reuptake inhibitor (SSRI) fluoxetine enhances neurogenesis, the new dual serotonergic-noradrenergic reuptake inhibitor (SNRI) duloxetine has not been evaluated in this context. In addition, it is unclear whether effects of antidepressants and running on cell genesis and behavior are of similar magnitude in mice. Here, we assessed neurogenesis and open-field behavior in 2-month-old female C57Bl/6 mice after 28days of treatment with either fluoxetine (18mg/kg), duloxetine (2, 6 or 18mg/kg) or exercise. New cell survival, as measured by 5-bromo-2'-deoxyuridine (BrdU)-labeled cells, was enhanced by 200% in the running group only. Both running and fluoxetine, but not duloxetine, increased the percentage of new cells that became neurons. In the open-field test, animals treated with either drug spent less time in the center than controls and runners. In addition, fluoxetine treatment resulted in reduced locomotor activity. Together, these data show that the neurogenic response to exercise is much stronger than to antidepressants and imply a low likelihood that anxiolytic effects of these drugs are mediated by adult neurogenesis in C57Bl/6 mice.

Published by Elsevier B.V.

PubMed Disclaimer

Figures

Figure 1

Figure 1. Locomotor activity in the open field

a. Mice on the SSRI fluoxetine traveled a smaller distance than controls (p<0.047) or runners (p<0.057). b. Mice on fluoxetine (p<0.016) and duloxetine (6 and 18 mg/kg), (p<0.05) spent significantly less time in the center and more time in the periphery of the maze than controls and runners. N=6 mice per group, error bars indicate SEM. *p<0.05.

Figure 2

Figure 2. The effects of running and antidepressants on cell survival and neurogenesis

Representative photomicrographs (a. control, b. duloxetine 6 mg/kg, c. fluoxetine 18 mg/kg, d. runner) of the SGZ demonstrate the location of BrdU labeled cells (green) within the contour of the DG labeled with NeuN (red). e. Running mice had a more than 2-fold increase in the number of surviving BrdU labeled cells. f. Fluoxetine and running both significantly increased the percentage of BrdU cells co-localizing with the neuronal marker (NeuN). N=6 mice per group, error bars indicate SEM. *p<0.003.

Similar articles

Cited by

References

    1. Alexander JL. Quest for timely detection and treatment of women with depression. J Manag Care Pharm. 2007;13:S3–S11. - PMC - PubMed
    1. Anderson JC, et al. DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population. Arch Gen Psychiatry. 1987;44:69–76. - PubMed
    1. Angst J, Dobler-Mikola A. The Zurich Study. V. Anxiety and phobia in young adults. Eur Arch Psychiatry Neurol Sci. 1985;235:171–178. - PubMed
    1. Bar M. A cognitive neuroscience hypothesis of mood and depression. Trends Cogn Sci. 2009;13:456–463. - PMC - PubMed
    1. Blumenthal JA, et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med. 2007;69:587–596. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources